Literature DB >> 31463092

Acute adverse drug reactions following cardiac catheterization: evidence-based guidance for providers and systems.

Spencer W Trooboff1, Alexander Iribarne2.   

Abstract

Entities:  

Year:  2019        PMID： 31463092      PMCID： PMC6688027          DOI： 10.21037/jtd.2019.06.64

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Adverse drug reactions: definitions, diagnosis, and management.

Authors:  I R Edwards; J K Aronson
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.

Authors:  M E Bertrand; E Esplugas; J Piessens; W Rasch
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

3.  Epidemiology and prognostic implications of contrast-induced nephropathy.

Authors:  Peter A McCullough; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Fulvio Stacul; James Tumlin
Journal:  Am J Cardiol       Date:  2006-02-10       Impact factor: 2.778

4.  The diagnosis and management of anaphylaxis: an updated practice parameter.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

5.  Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations.

Authors:  H Vernon Anderson; Richard E Shaw; Ralph G Brindis; Charles R McKay; Lloyd W Klein; Ronald J Krone; Kalon K L Ho; John S Rumsfeld; Sidney C Smith; William S Weintraub
Journal:  Am J Cardiol       Date:  2006-11-16       Impact factor: 2.778

6.  A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.

Authors:  B J Barrett; P S Parfrey; H M Vavasour; F O'Dea; G Kent; E Stone
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

7.  Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I).

Authors:  T J Noto; L W Johnson; R Krone; W F Weaver; D A Clark; J R Kramer; G W Vetrovec
Journal:  Cathet Cardiovasc Diagn       Date:  1991-10

Review 8.  Use of epinephrine in the treatment of anaphylaxis.

Authors:  Phil Lieberman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-08

9.  Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

Authors:  Giancarlo Marenzi; Emilio Assanelli; Jeness Campodonico; Gianfranco Lauri; Ivana Marana; Monica De Metrio; Marco Moltrasio; Marco Grazi; Mara Rubino; Fabrizio Veglia; Franco Fabbiocchi; Antonio L Bartorelli
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

10.  Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy?

Authors:  Jiri Trcka; Claudia Schmidt; Cornelia S Seitz; Eva-B Bröcker; Gerd E Gross; Axel Trautmann
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.